Notably, HLA-A*02 and HLA-B*44 are both protective for the development of MS [28–30], a chronic inflammatory disease of the central nervous system driven by the interaction of genetic and environmental factors [36]. This evidence concerns the gene HLA-B and myeloid sarcoma.